Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Bayer AG

WKN: BAY001 / Symbol: BAYZF / Name: Bayer / Stock / Pharmaceuticals / Large Cap /

€48.10
-2.130%

BAYER AG

WKN: A255C9 / Name: BAYER / Stock / ? /

€99.41
-0.500%

BAYER AG

WKN: A289QF / Name: BAYER / Stock / ? /

€99.16
-0.160%

BAYER AG

WKN: A289QG / Name: BAYER / Stock / ? /

€92.72
0.160%

BAYER AG

WKN: A289QH / Name: BAYER / Stock / ? /

€87.50
-0.230%

BAYER AG

WKN: A3H3EV / Name: BAYER / Stock / ? /

€93.44
-0.150%

BAYER AG

WKN: A3H3EW / Name: BAYER / Stock / ? /

€86.90
0.100%

BAYER AG

WKN: A3H3EX / Name: BAYER / Stock / ? /

€76.19
-0.480%

BAYER AG

WKN: A3MQSV / Name: BAYER / Stock / ? /

€100.60
-0.270%

BAYER AG

WKN: A3MQSW / Name: BAYER / Stock / ? /

€102.64
-0.200%

BAYER AG

WKN: A351U0 / Name: BAYER / Stock / ? /

€102.92
0.170%

BAYER AG

WKN: A351UZ / Name: BAYER / Stock / ? /

€100.01
-1.020%

BAYER AG

WKN: A351U1 / Name: BAYER / Stock / ? /

€104.59
0.070%

BAYER AG

WKN: A3514W / Name: BAYER / Stock / ? /

€105.06
-0.240%

BAYER AG

WKN: A383Q8 / Name: BAYER / Stock / ? /

€103.37
0.240%

BAYER AG

WKN: A4DFV1 / Name: BAYER / Stock / ? /

€100.22
-

Bayer AG ADR

WKN: 879501 / Symbol: BAYRY / Name: Bayer / Stock / Pharmaceuticals / Large Cap /

€12.00
0.840%

Bayer Aktiengesellschaft Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Bayer Aktiengesellschaft Q2 Earnings Call Highlights

Bayer Aktiengesellschaft (ETR:BAYN) said first-half sales rose 3% on a currency- and portfolio-adjusted basis to €24.3 billion, as growth in Crop Science and

Bayer Aktie: 76,67 Prozent Plus in zwölf MonatenPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Bayer Aktie: 76,67 Prozent Plus in zwölf Monaten

Bayer galt jahrelang als Synonym für hausgemachte Krisen. Glyphosat-Klagen, Schuldenberg, ein Aktienkurs im Dauerabwärtstrend.…

Der Beitrag Bayer Aktie: 76,67 Prozent Plus in zwölf Monaten erschien

Bayer Aktie: Glyphosat-Anhörung frühestens am 14. SeptemberPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Bayer Aktie: Glyphosat-Anhörung frühestens am 14. September

Bayer und die Klägerseite im US-Glyphosat-Streit haben gemeinsam beantragt, die Anhörung zur endgültigen Genehmigung…

Der Beitrag Bayer Aktie: Glyphosat-Anhörung frühestens am 14. September erschien